Survey of the occurrence of pharmaceuticals in Spanish finished drinking waters

Environmental Science and Pollution Research

Volumn 21, Issue 18, 2014, Pages 10917-10939

  Boleda, M Rosa ^a   Alechaga, Élida ^b   Moyano, Encarnación ^b   Galceran, M Teresa ^b   Ventura, Francesc ^a,c  

^a S A Laboratory   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUTE OF ENVIRONMENTAL ASSESSMENT AND WATER RESEARCH   (Spain)

Author keywords

ATC code; FDW; LC HRMS; LC MS MS; Pharmaceuticals

Indexed keywords

DRINKING WATER; DRUG; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; SAMPLING;

SPAIN;

AZITHROMYCIN; CLARITHROMYCIN; DRINKING WATER; DRUG; ERYTHROMYCIN; IBUPROFEN; SULFAMETHOXAZOLE; WATER POLLUTANT;

ANALYSIS; CHEMISTRY; ENVIRONMENTAL MONITORING; LIQUID CHROMATOGRAPHY; PROCEDURES; SPAIN; STATISTICS AND NUMERICAL DATA; TANDEM MASS SPECTROMETRY; WATER POLLUTANT;

AZITHROMYCIN; CHROMATOGRAPHY, LIQUID; CLARITHROMYCIN; DRINKING WATER; ENVIRONMENTAL MONITORING; ERYTHROMYCIN; IBUPROFEN; PHARMACEUTICAL PREPARATIONS; SPAIN; SULFAMETHOXAZOLE; TANDEM MASS SPECTROMETRY; WATER POLLUTANTS, CHEMICAL;

EID: 84907860930     PISSN: 09441344     EISSN: 16147499     Source Type: Journal    
DOI: 10.1007/s11356-014-2885-9     Document Type: Article

References (105)

1. Acero JL, Benitez FJ, Real FJ, Roldan G (2010) Kinetics of aqueous chlorination of some pharmaceuticals and their elimination from water matrices. Water Res 44:4158–4170
2. Adams C, Wang Y, Loftin K, Meyer M (2002) Removal of antibiotics from surface and distilled water in conventional water treatment processes. J Environ Eng 128:253–260
3. Antoniou MG, Hey G, Rodriguez Vega S, Spiliotopoulou A, Fick J, Tysklind M, la Cour JJ, Andersen HR (2013) Required ozone doses for removing pharmaceuticals from wastewater effluents. Sci Total Environ 456–457:42–49
4. Bandu ML, Watkins KR, Bretthauer ML, Moore CA, Desaire H (2004) Prediction of MS/MS Data. 1. A Focus on Pharmaceuticals Containing Carboxylic Acids. Anal Chem 76:1746–1753
5. Bedner M, MacCrehan WA (2006) Transformation of acetaminophen by chlorination produces the toxicants 1,4-benzoquinone and N-acetyl-p-benzoquinone imine. Environ Sci Technol 40:516–522
6. Benitez FJ, Acero J.L., Real FJ, Roldan G (2009) Ozonation of pharmaceutical compounds: Rate constants and elimination in various water matrices. Chemosphere 77
7. Benotti MJ, Trenholm RA, Vanderford BJ, Holady JC, Standford BD, Snyder SA (2009) Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environ Sci Technol 43:597–603
8. Besse JP, Garric J (2008) Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation. Toxicol Lett 176:104–123
9. Boix C, Ibañez M, Sancho JV, Niessen WMA, Hernandez F (2013) Investigating the presence of omeprazole in waters by liquid chromatography coupled to low and high resolution mass spectrometry: degradation experiments. J Mass Spectrom 48:1091–1100
10. Boleda MR, Galceran MT, Ventura F (2011) Behavior of pharmaceuticals and drugs of abuse in a drinking water treatment plant (DWTP) using combined conventional and ultrafiltration and reverse osmosis (UF/RO) treatments. Environ Pollut 159:1584–1591
11. Boleda MR, Galceran MT, Ventura F (2013) Validation and uncertainty estimation of a multiresidue method for pharmaceuticals in surface and treated waters by liquid chromatography-tandem mass spectrometry. J Chromatogr A 1286:146–158
12. Boxall ABA, Monteiro SC, Fussell R, Williams RJ, Bruemer J, Greenwood R, Bersuder P (2011) Targeted monitoring for human pharmaceuticals in vulnerable source and final waters Drinking Water Inspectorate (DWI). Project nº WD0805 (ref DWI 70/2/231)
13. Boyd GR, Zhang S, Grimm DA (2005) Naproxen removal from water by chlorination and biofilm processes. Water Res 39:668–676
14. Bruchet A, Hochereau C, Picard C, Decottignies V, Rodrigues JM, Janex-Habibi ML (2005) Analysis of drugs and personal care products in French source and drinking waters: the analytical challenge and examples of application. Water Sci Technol 52:53–61
15. Bulloch DN, Lavado R, Forsgren KL, Beni S, Schlenk D, Larive CK (2012) Analytical and biological characterization of halogenated gemfibrozil produced through chlorination of wastewater. Environ Sci Technol 46:5583–5589
16. Daughton CG (2003) Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. I. Rational for and avenues toward a green pharmacy. Environ Health Perspect 111:757–774
17. Daughton CG (2010) Pharmaceutical ingredients in drinking water: Overview of occurrence and significance of human exposure. In: Holden R (ed) Contaminants of Emerging Concern in the Environment: Ecological and Human Health Considerations. ACS Symposium Series 1048. American Chemical Society: Washington, D.C., Chapter 2. pp 9–68, 2 November 2010
18. Daughton CG, Ruhoy IS (2009) Environmental footprint of pharmaceuticals: the significance of factors beyond direct excretion to sewers. Environ Toxicol Chem 28:2495–2521
19. Daughton CG, Scuderi MST (2013) Pharmaceuticals and Personal Care Products (PPCPs): Relevant Literature, U.S. Environmental Protection Agency, Las Vegas, NV (a comprehensive database of literature references; first implemented 19 February 2008). Available from http://www.epa.gov/ppcp/lit.html
20. De Voogt P, Janex-Habibi ML, Sacher F, Puijker L, Mons M (2009) Development of a common priority list of pharmaceuticals relevant for the water cycle. Water Sci Technol 59:39–49
21. Deborde M, von Gunten U (2008) Reactions of chlorine with inorganic and organic compounds during water treatment. Kinetics and mechanisms: a critical review. Water Res 42:13–51
22. Dodd MC, Buffle MO, von Gunten U (2006) Oxidation of antibacterial molecules by aqueous ozone: moiety-specific reaction kinetics and application to ozone-based wastewater treatment. Environ Sci Technol 40:1969–1977
23. Esteban S, Valcárcel Y, Catalá M, González-Castromil M (2012) Psychoactive pharmaceutical residues in the watersheds of Galicia (Spain). Gac Sanit 26:457–459
24. Farre M, Ferrer I, Ginebreda A, Figueras M, Olivella L, Tirapu L, Vilanova M, Barceló D (2001) Determination of drugs in surface water and wastewater samples by liquid chromatography–mass spectrometry: methods and preliminary results including toxicity studies with Vibrio fischeri. J Chromatogr A 938:187–197
25. Fedorova G, Randak T, Lindberg RH, Grabic R (2013) Comparison of the quantitative performance of a Q-Exactive high-resolution mass spectrometer with that of a triple quadrupole tandem mass spectrometer for the analysis of illicit drugs in wastewater. Rapid Commun Mass Spectrom 27:1751–1762
26. Fernández C, González-Doncel M, Pro J, Carbonell G, Tarazona JV (2010) Occurrence of pharmaceutically active compounds in surface waters of the Henares-Jarama-Tajo river system (Madrid, Spain) and a potential risk characterization. Sci Total Environ 408:543–551
27. Ferreira da Silva B, Jelic A, López-Serna R, Mozeto AA, Petrovic M, Barceló D (2011) Occurrence and distribution of pharmaceuticals in surface water, suspended solids and sediments of the Ebro river basin, Spain. Chemosphere 85:1331–1339
28. García-Galán MJ, Villagrasa M, Díaz-Cruz MS, Barceló D (2010) LC-QqLIT MS análisis of nine sulfonamides and one of their acetylated metabolites in the Llobregat river basin. Quantitative determination and qualitative evaluation by IDA experiments. Anal Bioanal Chem 397:1325–1334
29. García-Galán MJ, Díaz-Cruz MS, Barceló D (2011) Occurrence of sulfonamide residues along the Ebro river basin. Removal in wastewater treatment plants and environmental impact assessment. Environ Int 37:462–473
30. Giri RR, Ozaki H, Ota S, Takanami R, Taniguchi S (2010) Degradation of common pharmaceuticals and personal care products in mixed solutions by advanced oxidation techniques. Int J Environ Sci Technol 7:251–260
31. Gonçalves C, Perez S, Osorio V, Petrovic M, Alpendurada MF, Barceló D (2011) Photofate of oseltamivir (tamiflu) and oseltamivir carboxylate under natural and simulated solar irradiation: kinetics, identification of the transformation products, and environmental occurrence. Environ Sci Technol 45:4307–4314
32. González-Alonso S, Catalá M, Romo-Maroto R, Rodríguez-Gil JL, Gil-de Miguel A, Valcárcel Y (2010) Pollution by psychoactive pharmaceuticals in the rivers of Madrid metropolitan area (Spain). Environ Int 36:195–201
33. Gracia-Lor E, Sancho JV, Hernández F (2010) Simultaneous determination of acidic, neutral and basic pharmaceuticals in urban wastewater by ultra high-pressure liquid chromatography-tandem mass spectrometry. J Chromatogr A 1217:622–632
34. Gros M, Petrović M, Barceló D (2006) Development of a multi-residue analytical methodology based on liquid chromatography–tandem mass spectrometry (LC–MS/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters. Talanta 70:678–690
35. Gros M, Petrović M, Barceló D (2007) Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the Ebro river basin (Northeast Spain). Environ Toxicol Chem 26:1553–1562
36. Gros M, Petrović M, Barceló D (2008) Tracing pharmaceutical residues of different therapeutic classes in environmental waters by using liquid chromatography/quadrupole-linear ion trap mass spectrometry and automated library searching. Anal Chem 81:898–912
37. Gros M, Rodriguez-Mozaz S, Barceló D (2013) Fast and comprehensive multi-residue analysis of a broad range of human and veterinary pharmaceuticals and some of their metabolites in surface and treated waters by ultra-high performance liquid chromatography coupled to quadrupole-linear ion trap tandem mass spectrometry. J Chromatogr A 1248:104–121
38. Grujić S, Vasiljević T, Laušević M (2009) Determination of multiple pharmaceutical classes in surface and ground waters by liquid chromatography–ion trap–tandem mass spectrometry. J Chromatogr A 1216:4989–5000
39. Hey G, Grabic R, Ledin A, la Cour Jansen J, Andersen HR (2012) Oxidation of pharmaceuticals by chlorine dioxide in biologically treated wastewater. Chem Eng J 185–186:236–242
40. Hirsch RT, Ternes TA, Lindart A, Haberer K, Wilken RD (2000) A sensitive method for the determination of iodine containing diagnostic agents in aqueous matrices using LC-electrospray-tandem-MS detection Fresenius’. J Anal Chem 366:835–841
41. Huber M, Canonica S, Park G-Y, von Gunten U (2003) Oxidation of pharmaceuticals during ozonation and advanced oxidation processes. Environ Sci Technol 37:1016–1024
42. Huber M, Korhonen S, Ternes TA, von Gunten U (2005) Oxidation of pharmaceuticals during water treatment with chlorine dioxide. Water Res 39:3607–3617
43. Huerta-Fontela M, Galceran MT, Ventura F (2011) Occurrence and removal of pharmaceuticals and hormones through drinking water treatment. Water Res 45:1432–1442
44. Hughes SR, Kay P, Brown LE (2013) Global synthesis and critical evaluation of pharmaceutical data sets collected from river systems. Environ Sci Technol 47:661–677
45. Iglesias A, Nebot C, Miranda JM, Vazquez BI, Cepeda A (2012) Detection and quantitative analysis of 21 veterinary drugs in river water using high-pressure liquid chromatography coupled to tandem mass spectrometry. Environ Sci Pollut Res 19:3235–3249
46. Jones OA, Lester JN, Voulvoulis N (2005) Pharmaceuticals: a threat to drinking water? Trends Biotechnol 23:163–167
47. Khetan SK, Collins TJ (2007) Human Pharmaceuticals in the aquatic environment: a challenge to green chemistry. Chem Rev 107:2319–2364
48. Kleywegt S, Pileggi V, Yang P, Hao C, Zhao X, Rocks C, Thach S, Cheung P, Whitehead B (2011) Pharmaceuticals, hormones and bisphenol A in untreated source and finished water in Ontario, Canada-Occurrence and treatment efficiency. Sci Total Environ 409:1481–1488
49. Köck-Schulmeyer M, Ginebreda A, Postigo C, López-Serna R, Pérez S, Brix R, Llorca M, López de Alda M, Petrovic M, Munné A, Tirapu L, Barceló D (2011) Wastewater reuse in Mediterranean semi-arid areas: the impact of discharges of tertiary treated sewage on the load of polar micro pollutants in the Llobregat river (NE Spain). Chemosphere 82:670–678
50. Kormos JL, Schulz M, Wagner M, Ternes TA (2009) Multistep approach for the structural identification of biotransformation products of iodinated X-ray contrast media by liquid chromatography/hybrid triple quadrupole linear ion trap mass spectrometry and 1H and 13C nuclear magnetic resonance. Anal Chem 81:9216–9224
51. Kormos JL, Schulz M, Ternes TA (2011) Occurrence of iodinated X-ray contrast media and their biotransformation products in the urban water cycle. Environ Sci Technol 45:8723–8732
52. Krkosek WH, Koziar SA, White RL, Gagnon GA (2011) Identification of reaction products from reactions of free chlorine with the lipid-regulator gemfibrozil. Water Res 45:1414–1422
53. Kümmerer K (2009a) Antibiotics in the aquatic environment. Part I. Chemosphere 75:417–434
54. Kümmerer K (2009b) Antibiotics in the aquatic environment. Part II. Chemosphere 75:435–441
55. Kuster M, López de Alda MJ, Hernando MD, Petrovic M, Martín-Alonso J, Barceló D (2008) Analysis and occurrence of pharmaceuticals, estrogens, progestogens and polar pesticides in sewage treatment plant effluents, river water and drinking water in the Llobregat river basin (Barcelona, Spain). J Hydrol 358:112–123
56. Lapworth DJ, Baran N, Stuart ME, Ward RS (2012) Emerging organic contaminants in groundwater: a review of sources, fate and occurrence. Environ Pollut 163:287–303
57. Loos R, Locoro G, Comero S, Contini S, Schwesig D, Werres F, Balsaa P, Gans O, Weiss S, Blaha L, Bolchi M, Gawlik BM (2010) Pan-European survey on the occurrence of selected polar organic persistent pollutants in ground water. Water Res 44:4115–4126
58. López-Roldan R, López de Alda MJ, Gros M, Petrovic M, Martin-Alonso J, Barceló D (2010) Advanced monitoring of pharmaceuticals and estrogens in the Llobregat river basin (Spain) by liquid chromatography-triple quadrupole tandem mass spectrometry in combination with ultra performance liquid chromatography-time of flight mass spectrometry. Chemosphere 80:1337–1344
59. López-Serna R, Petrovic M, Barceló D (2011) Development of a fast instrumental method for the analysis of pharmaceuticals in environmental and wastewaters based on ultra high performance liquid chromatography (UHPLC)–tandem mass spectrometry (MS/MS). Chemosphere 85:1390–1399
60. López-Serna RPC, Blanco J, Pérez S, Ginebreda A, López de Alda M, Petrovic M, Munné A, Barceló D (2012) Assessing the effects of tertiary treated wastewater reuse on the presence emerging contaminants in a Mediterranean river (Llobregat, NE Spain). Environ Sci Pollut Res 19:1000–1012
61. Loraine GA, Pettigrove ME (2006) Seasonal variations in concentrations of pharmaceuticals and personal care products in drinking water and reclaimed wastewater in Southern California. Environ Sci Technol 40:687–695
62. Marchese S, Gentili A, Perret D, Ascenzo GD, Pastori F (2003) Quadrupole time-of-flight versus triple-quadrupole mass spectrometry for the determination of non-steroidal antiinflammatory drugs in surface water by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 17:879–886
63. Martın J, Camacho-Muñoz D, Santos JL, Aparicio I, Alonso E (2011) Monitoring of pharmaceutically active compounds on the Guadalquivir River basin (Spain): occurrence and risk assessment. J Environ Monit 13:2042–2050
64. Martínez Bueno MJ, Agüera A, Gómez MJ, Hernando MD, García-Reyes JF, Fernández-Alba AR (2007) Application of liquid chromatography/quadrupole-linear ion trap mass spectrometry and time-of-flight mass spectrometry to the determination of pharmaceuticals and related contaminants in wastewater. Anal Chem 79:9372–9384
65. Martínez Bueno MJ, Hernando MD, Herrera S, Gómez MJ, Fernández-Alba AR, Bustamante I, García-Calvo E (2010) Pilot survey of chemical contaminants from industrial and human activities in river waters of Spain. Int J Environ Anal Chem 90:321–343
66. McAvoy DC, Schatowitz B, Jacob M, Hauk A, Eckhoff WS (2002) Measurement of triclosan in wastewater treatment systems. Environ Toxicol Chem 21:1323–1329
67. Mompelat S, Le Bot B, Thomas O (2009) Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water. Environ Int 35:803–814
68. Monteiro SC, Boxall ABA (2010) Occurrence and fate of human pharmaceuticals in the environment. Rev Environ Contam Toxicol 202:53–153
69. Muñoz I, López-Doval J, Ricart M, Villagrasa M, Brix R, Geiszinger A, Ginebreda A, Guasch H, López de Alda MJ, Romani AM, Sabater S, Barceló D (2009) Bridging levels of pharmaceuticals in river water with biological community structure in the Llobregat river (Northeast Spain). Environ Toxicol Chem 28:2706–2714
70. Nakada N, Shinohara H, Murata A, Kiri K, Managaki S, Sato N, Takada H (2007) Removal of selected pharmaceuticals and personal care products (PPCPs) and endocrine-disrupting chemicals (EDCs) during sand filtration and ozonation at a municipal sewage treatment plant. Water Res 41:4373–4382
71. Nebot C, Gibb SW, Boyd KG (2007) Quantification of human pharmaceuticals in water samples by high performance liquid chromatography–tandem mass spectrometry. Anal Chim Acta 598:87–94
72. Nieto A, Peschka M, Borrull F, Pocurull E, Marcé RM, Knepper TP (2010) Phosphodiesterase type V inhibitors: occurrence and fate of wastewater and sewage sludge. Water Res 44:1607–1615
73. Ontario MOE Survey of the Occurrence of Pharmaceuticals and Other Emerging Contaminants in Untreated Source and Finished Drinking Water in Ontario. Ontario Ministry of the Environment (MOE), Canada, 2010, 31 pp. Avaiable from http://www.ene.gov.on.ca/publications/7269e.pdf
74. Pedrouzo N, Reverté S, Borrull F, Pocurull E, Marcé RM (2007) Pharmaceutical determination in surface and wastewaters using high-performance liquid chromatography-(electrospray)-mass spectrometry. J Sep Sci 30:297–303
75. Pedrouzo N, Borrull F, Pocurull E, Marcé RM (2008) Simultaneous determination of macrolide sulfonamides, and other pharmaceuticals in water samples by solid-phase extraction and LC-(ESI) MS. J Sep Sci 31:2182–2188
76. Peschka M, Eubeler JP, Knepper TP (2006) Occurrence and fate of barbiturates in the aquatic environment. Environ Sci Technol 40:7200–7206
77. Phillips PJ, Smith SG, Kolpin DW, Zaugg SD, Buxton HT, Furlong ET, Esposito K, Stinson B (2010) Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater treatment plant effluents. Environ Sci Technol 44:4910–4916
78. Pinkston KE, Sedlak DL (2004) Transformation of aromatic ether- and amine-containing pharmaceuticals during chlorine disinfection. Environ Sci Technol 38:4019–4025
79. Quintana JB, Rodil R, Lopez-Mahia P, Muniategui-Lorenzo S, Prada-Rodriguez D (2010) Investigating the chlorination of acidic pharmaceuticals and by-product formation aided by an experimental design methodology. Water Res 44:243–255
80. Rodil R, Quintana JB, Concha-Graña E, Lopez-Mahia P, Muniategui-Lorenzo S, Prada-Rodriguez D (2012) Emerging pollutants in sewage, surface and drinking water in Galicia (NW Spain). Chemosphere 86:1040–1049
81. Rodriguez-Mozaz S, López de Alda MJ, Barceló D (2004a) Picogram per liter level determination of estrogens in natural waters and waterworks by a fully automated on-line solid-phase extraction-liquid chromatography-electrospray tandem mass spectrometry method. Anal Chem 76:6998–7006
82. Rodriguez-Mozaz S, López de Alda MJ, Barceló D (2004b) Monitoring of estrogens, pesticides and bisphenol A in natural waters and drinking water treatment plants by solid-phase extraction–liquid chromatography–mass spectrometry. J Chromatogr A 1045:85–92
83. Rosal R, Rodríguez A, Perdigón-Melón JA, Petre A, García-Calvo E, Gómez MJ, Agüera A, Fernández-Alba A (2010) Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. Water Res 44:578–588
84. Seitz W, Jiang JQ, Weber WH, Lloyd BJ, Maier M, Maier D (2006) Removal of iodinated X-ray contrast media during drinking water treatment. Environ Chem Lett 3:35–39
85. Shah AD, Kim J-H, Huang C-H (2006) Reaction kinetics and transformation of carbadox and structurally related compounds with aqueous chlorine. Environ Sci Technol 40:7228–7235
86. Simazaki D, Fujiwara J, Manabe S, Matsuda M, Asami M, Kunikane S (2008) Removal of selected pharmaceuticals by chlorination coagulation-sedimentation and powdered activated carbon treatment. Water Sci Technol 58:1129–1135
87. Snyder SA (2008) Occurrence, treatment, and toxicological relevance of EDCs and pharmaceuticals in water. Ozone Sci Eng 30:65–69
88. Snyder SA, Lei H, Wert EC (2007) In: Aga DS (ed) Fate of pharmaceuticals in the environment and in water treatment systems. CRC Press, Boca Raton, pp 229–260
89. Stackelberg PE, Furlong ET, Meyer MT, Zaugg DD, Henderson AK, Reismann DB (2004) Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking water treatment plant. SciTotal Environ 329:99–113
90. Swindyard EA, Miyahara JT, Goodman LS (1963) Effect of chlorination on the anticonvulsant activity of phenobarbital. J Pharm Sci 52:463–465
91. Ternes T (2001) In: Daughton CG, Jones-Lepp TL (eds) Pharmaceuticals and personal care products in the environment: scientific and regulatory issues. American Chemical Society, Washington, DC, pp 39–54
92. Ternes TA, Meisenheimer M, McDowell D, Sacher F, Brauch HJ, Gulde BH, Preuss G, Wilme U, Seibert NZ (2002) Removal of pharmaceuticals during drinking water treatment. Environ Sci Technol 36:3855–3863
93. Trenholm RA, Vanderford BJ, Holady JC, Rexing DJ, Snyder SA (2006) Broad range analysis of endocrine disruptors and pharmaceuticals using gas chromatography and liquid chromatography tandem mass spectrometry. Chemosphere 65:1990–1998
94. Valcárcel Y, González-Alonso S, Rodriguez-Gil JL, Gil A, Catalá M (2011a) Detection of pharmaceutically active compounds in the rivers and tap water of the Madrid Region (Spain) and potential ecotoxicological risk. Chemosphere 86:1336–1348
95. Valcárcel Y, González-Alonso S, Rodríguez-Gil JL, Romo-Maroto R, Gil A, Catalá M (2011b) Analysis of the presence of cardiovascular and analgesic/anti-inflammatory/antypiretic pharmaceuticals in river- and drinking water of the Madrid Region in Spain. Chemosphere 82:1062–1071
96. Valcárcel Y, González-Alonso S, Rodriguez-Gil JL, Castaño A, Montero JC, Criado-Alvarez JJ, Mirón IJ, Catalá M (2013) Seasonal variation of pharmaceutically active compounds in surface (Tagus River) and tap water (Central Spain). Environ Sci Pollut Res 20:1396–1412
97. Van der Aa NGFM, Dijkman E, Bijlsma L, Emke E, van de Ven BM, van Nuijs ALN, de Voogt P (2010) Drugs of abuse and tranquilizers in Dutch surface waters, drinking waters and wastewater. RIVM Report 703719064/2010
98. Versteegh JFM, van der Aa NGFM, Dijkman E (2007) Pharmaceuticals in drinking water and resources for drinking water: Results of the measurement program 2005/2006, 2007, RIVM report 703719016/2007, Rijksinstituut voor Volksgezondheid en Milieu RIVM, Bilthoven, The Netherlands, pp 1–53. Available from http://www.rivm.nl/bibliotheek/rapporten/703719016.html
99. 2 and ozone. Water Res 38:414–422
100. Von Gunten U (2003) Ozonation of drinking water: Part I. Oxidation kinetics and product formation. Water Res 37:1443–1467
101. Von Gunten U, Janex-Habibi ML, Ternes TA, Weber L (2006) Removal of PPCP during drinking water treatment. In: Ternes TA, Joss A (eds) Human pharmaceuticals, hormones and fragrances. IWA Publishing, London, pp 293–322
102. Vulliet E, Cren-Olive C, Grenier-Loustalot M-F (2011) Occurrence of pharmaceuticals and hormones in drinking water treated from surface waters. Environ Chem Lett 9:103–114
103. Wenzel AM, J., Ternes T (2003) Study of endocrine disrupters in drinking water. Final Report ENV.D.1/ETU/2000/0083, Fraunhofer Institute for Molecular Biology and Applied Ecology, Schmallenberg, Germany. Available from http://ec.europa.eu/research/endocrine/pdf/drinking_water_en.pdf
104. Westerhoff P, Yoon Y, Snyder S, Wert E (2005) Fate of endocrine-disruptor pharmaceutical and personal care product chemicals during simulated drinking water treatment processes. Environ Sci Technol 39:6649–6663
105. Zuccato E, Calamari D, Natangelo M, Fanelli R (2000) Presence of therapeutic drugs in the environment. Lancet 355:1789–1790